Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) – protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)

After infection with SARS-CoV-2 a relevant proportion of patients complains about persisting symptoms, a condition termed Post-COVID-19-syndrome (PC19S). So far, possible treatments are under investigation. Am...

Source: BMC Infectious Diseases - January 6, 2024 Category: Infectious Diseases Authors: Caroline Tengelmann, Stefanie Joos, Yvonne Kau ßner, Uwe Malzahn, Laura Lunden, Andreas Klug, Karl Georg Häusler, Catharina Escales, Walter Maetzler, Klemens Hügen, Oliver Zolk, Peter U. Heuschmann, Christian Förster, Hanna Kaduszkiewicz and Ildikó G Tags: Study Protocol Source Type: research